Title: Multi-modal OMICs inform new vulnerabilities in breast cancer treatment and prevention – May 4, 2022
Speaker: Rama Khokha, Ph.D.

Learning Objectives
Upon conclusion of the activity, participants should be able to:

• Identify the importance of reproductive hormones in contributing to factors that determine breast cancer risk
• Determine how our discovery-to-Intervention strategy has revealed new breast cancer cell vulnerabilities
• Conceive the concept of cell-of-origin in breast cancer subtypes

Audience: DLMP Staff

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures